Yifeng Pharmacy anticipates convertible bond price revision amid share buyback

Yifeng Pharmacy Chain announced an anticipated trigger for the downward revision of its "Yifeng convertible bonds" conversion price. As of September 30, 2025, the company's stock closing price has been below 85% of the current conversion price of 31.84 yuan per share for ten trading days. If the stock price falls below 27.06 yuan per share for five more trading days within the next twenty, the downward revision condition will be met. The company intends to convene a board meeting to decide on the revision and fulfill disclosure requirements.

This development coincides with the company's decision to repurchase and cancel 25,516 shares of restricted stock from its 2022 incentive plan, at a price of 14.43 yuan per share, totaling 36,820 yuan. This action is due to certain incentive recipients' departure, demotion, or failure to meet performance targets. The buyback will reduce the company's registered capital by 25,516 yuan.

The adjustment to the convertible bond's conversion price has seen multiple revisions since its initial 39.85 yuan per share, primarily due to dividend distributions in 2024 and 2025. The company emphasized no significant impact on its financial status or operations.